C-C Chemokine Receptor Type 9 (CCR9) Antibody
299€ (50 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
Name
C-C Chemokine Receptor Type 9 (CCR9) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx349868
Tested Applications
ELISA
Description
C-C Chemokine Receptor Type 9 (CCR9) Antibody is a Recombinant Human Monoclonal antibody for the detection of Human CCR9.
Documentos del producto
Instrucciones
Data sheet
Especificaciones del producto
| Category | Primary Antibodies |
| Immunogen Target | Target: C-C Chemokine Receptor Type 9 (CCR9) Immunogen: Recombinant Human CCR9 protein |
| Host | Human |
| Reactivity | Human |
| Recommended Dilution | Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Monoclonal |
| Conjugation | Unconjugated |
| Isotype | IgG1 |
| Expression | Recombinant |
| Purification | Purified by affinity chromatography. |
| Size 1 | 50 µl |
| Size 2 | 100 µl |
| Form | Liquid |
| Tested Applications | ELISA |
| Buffer | 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | P51686 |
| Gene ID | 10803 |
| Alias | CCR9,C-C motif chemokine receptor 9,CC-CKR-9,CDw199,GPR-9-6,GPR28, |
| Background | Antibody anti-CCR9 |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Background
C-C Chemokine Receptor Type 9 (CCR9) is a G-protein-coupled receptor highly expressed on T lymphocytes within the gut-associated lymphoid tissue (GALT) and plays a critical role in mucosal immunity. CCR9 binds its ligand CCL25 (TECK), which is predominantly expressed in the small intestine, guiding the homing of T cells to the intestinal epithelium. This receptor-ligand interaction is crucial for maintaining intestinal immune surveillance and protecting the gut from pathogens. CCR9 is particularly important for the migration of T-helper 1 (Th1) cells and memory T cells into the small intestine, where they contribute to immune homeostasis. However, CCR9 is also implicated in inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, where excessive T-cell migration to the gut exacerbates inflammation and tissue damage. In cancer, CCR9 is overexpressed in certain types of T-cell leukemias and gastrointestinal tumors, where it contributes to tumor growth and metastasis by enhancing immune cell recruitment. CCR9 has also been explored as a potential therapeutic target for intestinal inflammation and gastrointestinal cancers. Blocking CCR9-CCL25 signaling with targeted therapies, such as small-molecule inhibitors, has shown promise in reducing gut inflammation and preventing lymphocyte migration in preclinical and clinical studies. This makes CCR9 a pivotal player in intestinal immunity, chronic inflammation, and tumor biology.
Productos relacionados
C-C Chemokine Receptor Type 9 (CCR9) Antibody
The protein encoded by this gene is a member of the beta chemokine receptor family. It is predicted to be a seven transm…
Ver producto
C-C Chemokine Receptor Type 9 (CCR9) Antibody
CCR9 Antibody is a Rabbit Polyclonal against CCR9.…
Ver producto C-C Chemokine Receptor Type 9 (CCR9) Antibody
CCR9 Antibody is a Rabbit Polyclonal against CCR9.…
Ver producto